|
Volumn 61, Issue 9, 2005, Pages 621-625
|
Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
FLUOROBENZENE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
ROSUVASTATIN;
SULFONAMIDE;
WARFARIN;
ADULT;
ARTICLE;
BLOOD CLOTTING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG COMBINATION;
DRUG EFFECT;
DRUG INTERACTION;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
MALE;
ORAL DRUG ADMINISTRATION;
PROTHROMBIN TIME;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, ORAL;
ADULT;
ANTICOAGULANTS;
BLOOD COAGULATION;
CROSS-OVER STUDIES;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
FLUOROBENZENES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INTERNATIONAL NORMALIZED RATIO;
MALE;
PROTHROMBIN TIME;
PYRIMIDINES;
SULFONAMIDES;
WARFARIN;
|
EID: 33748097815
PISSN: 00316970
EISSN: None
Source Type: Journal
DOI: 10.1007/s00228-005-0986-6 Document Type: Article |
Times cited : (18)
|
References (0)
|